A BILL 
To report data on COVID–19 in Federal, State, and local 
correctional facilities, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘COVID–19 in Correc-
4
tions Data Transparency Act’’. 
5
SEC. 2. DEFINITIONS. 
6
In this Act: 
7
17:11 Mar 12, 2021
H1072
2 
•HR 1072 IH
(1) COVID–19.—The term ‘‘COVID–19’’ means 
1
Coronavirus Disease 2019. 
2
(2) COVID–19 DIAGNOSTIC
TEST.—The term 
3
‘‘COVID–19 diagnostic test’’ means a test— 
4
(A) that is an in vitro diagnostic product 
5
(as defined in section 809.3 of title 21, Code of 
6
Federal Regulations, or any successor thereto) 
7
for the detection of SARS–CoV–2 or the diag-
8
nosis of the virus that causes COVID–19; and 
9
(B) the administration of which— 
10
(i) is approved, cleared, or authorized 
11
under section 510(k), 513, 515, or 564 of 
12
the Federal Food, Drug, and Cosmetic Act 
13
(21 U.S.C. 360(k), 360c, 360e, 360bbb–3); 
14
(ii) the developer has requested, or in-
15
tends to request, emergency use authoriza-
16
tion under section 564 of the Federal 
17
Food, Drug, and Cosmetic Act (21 U.S.C. 
18
360bbb–3), unless and until the emergency 
19
use authorization request under such sec-
20
tion 564 has been denied or the developer 
21
of such test does not submit a request 
22
under such section within a reasonable 
23
timeframe; 
24
17:11 Mar 12, 2021
H1072
3 
•HR 1072 IH
(iii) is developed in and authorized by 
1
a State that has notified the Secretary of 
2
Health and Human Services of its inten-
3
tion to review tests intended to diagnose 
4
COVID–19; or 
5
(iv) is another test that the Secretary 
6
determines appropriate in guidance. 
7
(3) COVID–19 EMERGENCY DATA COLLECTION 
8
PERIOD.—The term ‘‘COVID–19 emergency data 
9
collection period’’ means the period beginning on the 
10
date of enactment of this Act and ending on the 
11
date that is 1 year after the date on which the pub-
12
lic health emergency declaration under section 319 
13
of the Public Health Service Act (42 U.S.C. 247d), 
14
with respect to COVID–19, terminates. 
15
(4) STATE
OR
LOCAL
CORRECTIONAL
FACIL-
16
ITY.—The term ‘‘State or local correctional facil-
17
ity’’— 
18
(A) means a correctional facility within the 
19
jurisdiction of a State or unit of local govern-
20
ment; and 
21
(B) includes— 
22
(i) a municipal, regional, or county 
23
jail; 
24
(ii) a State prison; 
25
17:11 Mar 12, 2021
H1072
4 
•HR 1072 IH
(iii) a State-run boot camp prison; 
1
(iv) a boot camp prison that is con-
2
tracted out by the State; 
3
(v) a State or local contract facility; 
4
(vi) a juvenile detention facility; 
5
(vii) a juvenile secure correctional fa-
6
cility; and 
7
(viii) any other local or State correc-
8
tional facility, including any juvenile facil-
9
ity. 
10
SEC. 3. BUREAU OF PRISONS AND UNITED STATES MAR-
11
SHALS SERVICE DATA COLLECTION. 
12
(a) BUREAU OF PRISONS.—The Director of the Bu-
13
reau of Prisons shall— 
14
(1) on a daily basis during the COVID–19 
15
emergency data collection period, make available to 
16
the public on the website of the Bureau of Prisons 
17
a report on the information described in section 6, 
18
with respect to incarcerated persons and staff; and 
19
(2) not later than 14 days after the date on 
20
which the Director of the Centers for Disease Con-
21
trol and Prevention publishes the guidance required 
22
under section 5(a), but in no case later than 45 days 
23
after the date of enactment of this Act, and not less 
24
frequently than once every 7 days thereafter until 
25
17:11 Mar 12, 2021
H1072
5 
•HR 1072 IH
the date on which the COVID–19 emergency data 
1
collection period ends, submit to the Director of the 
2
Centers for Disease Control and Prevention every 7 
3
days, a report on the information described in sec-
4
tion 6, with respect to incarcerated persons and 
5
staff. 
6
(b) UNITED STATES MARSHALS SERVICE.—The Di-
7
rector of the United States Marshals Service shall— 
8
(1) on a daily basis during the COVID–19 
9
emergency data collection period, make available to 
10
the public on the website of the United States Mar-
11
shals Service a report on the information described 
12
in section 6, with respect to incarcerated persons in 
13
the custody of the United States Marshals Service, 
14
including individuals held at or employed by a State 
15
or local correctional facility contracted by Federal 
16
entities; and 
17
(2) not later than 14 days after the date on 
18
which the Director of the Centers for Disease Con-
19
trol and Prevention publishes the guidance required 
20
under section 5(a), but in no case later than 45 days 
21
after the date of enactment of this Act, and not less 
22
frequently than once every 7 days thereafter until 
23
the date on which the COVID–19 emergency data 
24
collection period ends, submit to the Director of the 
25
17:11 Mar 12, 2021
H1072
6 
•HR 1072 IH
Centers for Disease Control and Prevention every 7 
1
days, a report on the information described in sec-
2
tion 6, with respect to incarcerated persons and 
3
staff. 
4
SEC. 4. STATE AND LOCAL CORRECTIONAL FACILITY DATA 
5
COLLECTION. 
6
(a) STATE AND LOCAL REPORTS.— 
7
(1) IN GENERAL.—Not later than 14 days after 
8
the date on which the Director of the Centers for 
9
Disease Control and Prevention publishes the guid-
10
ance required under section 5(a), but in no case 
11
later than 45 days after the date of enactment of 
12
this Act, and not less frequently than once every 7 
13
days thereafter until the date on which the COVID– 
14
19 emergency data collection period ends— 
15
(A) the head of each State department of 
16
corrections and the head of each State juvenile 
17
justice agency shall make available to the public 
18
on the website of the department, and submit 
19
to the public health authority of the State, the 
20
data described in section 6, with respect to in-
21
carcerated persons and staff; and 
22
(B) the head of each State or local correc-
23
tional facility shall submit to the public health 
24
authority of the State or unit of local govern-
25
17:11 Mar 12, 2021
H1072
7 
•HR 1072 IH
ment, as the case may be, the data described in 
1
section 6, with respect to incarcerated persons 
2
and staff. 
3
(2) SUBMISSION
OF
INFORMATION
TO
THE 
4
CDC.—Not later than 24 hours after a State or local 
5
public health authority receives data under para-
6
graph (1), the head of the State or local public 
7
health authority shall submit the data to the Direc-
8
tor of the Centers for Disease Control and Preven-
9
tion. 
10
(3) BYRNE GRANT AMOUNTS.— 
11
(A) IN GENERAL.—If a State or jurisdic-
12
tion within a State fails to comply with the re-
13
quirements under paragraphs (1) and (2) in a 
14
fiscal year, the amount the State would other-
15
wise be awarded in the following fiscal year 
16
under subpart 1 of part E of title I of the Om-
17
nibus Crime Control and Safe Streets Act of 
18
1968 (34 U.S.C. 10151 et seq.) shall be re-
19
duced by 10 percent. 
20
(B) REPORT ON COMPLIANCE TO DOJ.— 
21
For purposes of carrying out this paragraph, 
22
the Director of the Centers for Disease Control 
23
and Prevention shall, not later than 30 days 
24
after the date on which the Director first re-
25
17:11 Mar 12, 2021
H1072
8 
•HR 1072 IH
ceives data from a State or local public health 
1
authority and once every 30 days thereafter, 
2
submit to the Attorney General a report detail-
3
ing which States, if any, are not in compliance 
4
with this Act. 
5
(b) AUTHORIZATION OF APPROPRIATIONS.—There is 
6
authorized to be appropriated to the Director of the Cen-
7
ters for Disease Control and Prevention such sums as are 
8
necessary to carry out this section. 
9
SEC. 5. CDC REPORTS. 
10
(a) GUIDANCE.—Not later than 30 days after the 
11
date of enactment of this Act, the Director of the Centers 
12
for Disease Control and Prevention shall issue guidance 
13
for Federal, State, and local correctional facilities on— 
14
(1) the categories of data required to be re-
15
ported under this Act; and 
16
(2) how the Director will determine whether a 
17
State is in compliance with this Act. 
18
(b) PUBLICATION ON WEBSITE.—Not later than 7 
19
days after data is reported to the Centers for Disease Con-
20
trol and Prevention under section 3 or 4, the Director of 
21
the Centers for Disease Control and Prevention shall make 
22
the data available to the public on the website of the Cen-
23
ters for Disease Control and Prevention, including all data 
24
17:11 Mar 12, 2021
H1072
9 
•HR 1072 IH
reported by the Bureau of Prisons, the United States Mar-
1
shals Service, and State and local correctional facilities. 
2
(c) REPORTS TO CONGRESS.—Not later than 60 days 
3
after the date of enactment of this Act, and every 30 days 
4
thereafter until the date on which the COVID–19 emer-
5
gency data collection period ends, the Director of the Cen-
6
ters for Disease Control and Prevention shall compile and 
7
submit to Congress, including the Committees on the Ju-
8
diciary and Health, Education, Labor, and Pensions of the 
9
Senate and the Committees on the Judiciary and Energy 
10
and Commerce of the House of Representatives, a report 
11
on the information submitted by the Bureau of Prisons, 
12
the United States Marshals Service, and the head of each 
13
State department of corrections under sections 3 and 4, 
14
respectively. 
15
SEC. 6. COVID–19 DATA. 
16
(a) IN GENERAL.—The data described in this section 
17
is the following data for each Federal, State, or local cor-
18
rectional facility within a State: 
19
(1) TEST
NUMBERS.—COVID–19 diagnostic 
20
testing, including cumulative and new (since the pre-
21
vious report) counts of— 
22
(A) the number of incarcerated persons 
23
tested for COVID–19, disaggregated by first- 
24
time COVID–19 diagnostic tests and retests; 
25
17:11 Mar 12, 2021
H1072
10 
•HR 1072 IH
(B) the number of correctional facility 
1
staff tested for COVID–19, disaggregated by 
2
first-time COVID–19 diagnostic tests and 
3
retests; and 
4
(C) the COVID–19 diagnostic test devel-
5
oper and test name for each COVID–19 diag-
6
nostic test conducted. 
7
(2) TEST
RESULTS.—COVID–19 diagnostic 
8
testing outcomes, including cumulative and new 
9
(since the previous report) counts of— 
10
(A) the number of confirmed positive tests 
11
of COVID–19 among incarcerated persons, 
12
disaggregated by first-time COVID–19 diag-
13
nostic tests and retests; 
14
(B) the number of confirmed negative tests 
15
of COVID–19 among incarcerated persons, 
16
disaggregated by first-time COVID–19 diag-
17
nostic tests and retests; 
18
(C) the number of confirmed positive tests 
19
of COVID–19 among correctional facility staff, 
20
disaggregated by first-time COVID–19 diag-
21
nostic tests and retests; 
22
(D) the number of confirmed negative tests 
23
of COVID–19 among correctional facility staff, 
24
17:11 Mar 12, 2021
H1072
11 
•HR 1072 IH
disaggregated by first-time COVID–19 diag-
1
nostic tests and retests; 
2
(E) the number of COVID–19 diagnostic 
3
tests pending results, disaggregated by incarcer-
4
ated persons and correctional facility staff; 
5
(F) the average time between testing an 
6
incarcerated person for COVID–19 and receiv-
7
ing the results of the COVID–19 diagnostic 
8
test; and 
9
(G) the average time between testing a 
10
correctional facility employee for COVID–19 
11
and receiving the results of the COVID–19 di-
12
agnostic test. 
13
(3) CASE
OUTCOMES.—COVID–19 case out-
14
comes, including cumulative and new (since the pre-
15
vious report) counts of— 
16
(A) the number of incarcerated persons 
17
hospitalized with COVID–19; 
18
(B) the number of incarcerated persons 
19
who have recovered from COVID–19; 
20
(C) the number of incarcerated persons 
21
currently in quarantine or medical isolation for 
22
exposure to or infection with COVID–19; 
23
17:11 Mar 12, 2021
H1072
12 
•HR 1072 IH
(D) the number of incarcerated persons 
1
who have completed quarantine or been released 
2
from medical isolation; 
3
(E) the number of incarcerated persons 
4
who have died from a case of COVID–19; 
5
(F) the number of correctional facility 
6
staff hospitalized with COVID–19; 
7
(G) the number of correctional facility 
8
staff who have recovered from COVID–19; and 
9
(H) the number of correctional facility 
10
staff who have died from a case of COVID–19. 
11
(4) RELEASE OF INCARCERATED PERSONS.—In 
12
the case of incarcerated persons, data related to the 
13
release of such incarcerated persons, including indi-
14
viduals released to home confinement and pursuant 
15
to compassionate release, as a result of the COVID– 
16
19 public health emergency. 
17
(5) DAILY POPULATION.—Average daily popu-
18
lation, the number of individuals who were newly ad-
19
mitted to the facility, and the number of individuals 
20
who were released from the facility for the week pre-
21
ceding the COVID–19 emergency data collection pe-
22
riod and for all weeks during this period. 
23
(6) VACCINATIONS.—Data related to distribu-
24
tion of the COVID–19 vaccine, including— 
25
17:11 Mar 12, 2021
H1072
13 
•HR 1072 IH
(A) the policies of the facility relating to 
1
the distribution of the COVID–19 vaccination 
2
to incarcerated persons and correctional facility 
3
staff, including how the facility is prioritizing 
4
distribution, both among correctional facility 
5
staff and incarcerated persons, and any changes 
6
or updates made to the policies; 
7
(B) the total number of COVID–19 vac-
8
cine doses that the facility has received up to 
9
the date of the report; 
10
(C) the total number and percentage of in-
11
carcerated persons who— 
12
(i) have been offered a COVID–19 
13
vaccine; 
14
(ii) have received a first dose of the 
15
COVID–19 vaccine up to the date of the 
16
report; 
17
(iii) are fully vaccinated, either be-
18
cause the person received a second dose of 
19
the COVID–19 vaccine or because the 
20
COVID–19 vaccine the person received re-
21
quired only 1 dose; 
22
(iv) declined the COVID–19 vaccine; 
23
and 
24
17:11 Mar 12, 2021
H1072
14 
•HR 1072 IH
(v) are housed in a skilled nursing 
1
level housing unit or hospice and have— 
2
(I) not received the COVID–19 
3
vaccine; 
4
(II) accepted the COVID–19 vac-
5
cine; and 
6
(III) decline the COVID–19 vac-
7
cine; 
8
(D) the total number and percentage of 
9
correctional facility staff— 
10
(i) have been offered a COVID–19 
11
vaccine; 
12
(ii) have received a first dose of the 
13
COVID–19 vaccine in up to the date of the 
14
report; 
15
(iii) are fully vaccinated, either be-
16
cause the person received a second dose of 
17
the COVID–19 vaccine or because the 
18
COVID–19 vaccine the person received re-
19
quired only 1 dose; and 
20
(iv) declined the COVID–19 vaccine; 
21
and 
22
(E) in the case of incarcerated persons and 
23
correctional facility staff described in subpara-
24
graph (C)(iv) or (D)(iv), respectively, the 3 
25
17:11 Mar 12, 2021
H1072
15 
•HR 1072 IH
most common reasons given for declining the 
1
COVID–19 vaccine. 
2
(b) DISAGGREGATION OF DATA.—The data described 
3
in this section shall be disaggregated by sex (including sex-
4
ual orientation and gender identity), age, race, ethnicity, 
5
disability, and geography (including county and State). 
6
(c) INCARCERATED PERSONS DATA.—The data de-
7
scribed in this section with respect to incarcerated persons 
8
who are serving a term of imprisonment and who are in-
9
fected with COVID–19 shall include, to the extent prac-
10
ticable, the term of imprisonment imposed on such incar-
11
cerated persons and the time served on such term of im-
12
prisonment. 
13
SEC. 7. PRIVACY PROTECTIONS. 
14
Any data collected, stored, received, or published 
15
under this Act shall— 
16
(1) be so collected, stored, received, or pub-
17
lished in a manner that protects the privacy of indi-
18
viduals whose information is included in such data; 
19
(2) be de-identified or anonymized in a manner 
20
that protects the identity of all individuals whose in-
21
formation is included in such data; 
22
(3) comply with privacy protections provided 
23
under the regulations promulgated under section 
24
264(c) of the Health Insurance Portability and Ac-
25
17:11 Mar 12, 2021
H1072
16 
•HR 1072 IH
countability Act of 1996 (42 U.S.C. 1320d–2 note); 
1
and 
2
(4) be limited in use for the purpose of public 
3
health and be protected from all other internal use 
4
by any entity that collects, stores, or receives the 
5
data, including use of such data in determinations of 
6
eligibility (or continued eligibility) in health plans, 
7
and from any other inappropriate uses. 
8
Æ 
17:11 Mar 12, 2021
H1072
